Expanding evidence for the multiple dangers of epidemic abdominal obesity by Cameron, Adrian J. & Zimmet, Paul Z.
Deakin Research Online 
Deakin University’s institutional research repository 
DDeakin Research Online  
Research Online  
This is the authors’ final peer reviewed version of the item 
published as: 
Cameron, Adrian J. and Zimmet, Paul Z. 2008, Expanding evidence for the multiple 
dangers of epidemic abdominal obesity, Circulation, vol. 117, no. 13, pp. 1624-1626. 
 
 
 
Available from Deakin Research Online: 
http://hdl.handle.net/10536/DRO/DU:30021309  
 
 
 
Copyright : © 2008, American Heart Association, Inc. 
 
  
 
 
 
 
     
Circulation 
Title: Expanding Evidence for the Multiple Dangers of Epidemic Abdominal 
Obesity 
Adrian Cameron (MPH, Grad Dip Int’l Health) and Paul Zimmet 
International Diabetes Institute and Baker Heart Research Institute, Melbourne, 
Australia 
America’s  waistline has been expanding now for decades1, largely as a 
consequence of an obesogenic environment, with a car worshipping culture and 
take-away lifestyle par excellence2. No upper limit to the prevalence or extent of 
obesity is yet apparent, and many countries and communities worldwide are busily 
following the American lead. Accumulating research evidence suggests that the 
personal and economic costs of the obesity epidemic are immense3, driven by the 
obesity related increases in risk for conditions such as type 2 diabetes, the metabolic 
syndrome, cardiovascular disease (CVD), kidney disease, arthritis, cancer, asthma 
and sleep disordered breathing. In addition, there are decreases in self-esteem and 
quality of life.  
Numerous very large cohort studies have also firmly established obesity as being a 
strong and robust predictor of both overall and CVD mortality in men and women4-8. 
In most of the studies reported to date, waist circumference was not measured, with 
obesity measured using the body mass index (BMI), a crude measure of overall 
obesity, which, as multiple studies have now shown, is often not the best predictor of 
obesity related outcomes9-11. In this issue of Circulation, Zhang et al. expand on the 
already considerable evidence suggestive of a strong positive relationship between 
overall obesity (using BMI) and mortality, with a report from the large Nurses’ Health 
Study examining the impact of abdominal obesity (using waist circumference) and 
each of all-cause, cancer and CVD mortality in US women12. The study is well 
powered to examine such associations, with over 3500 deaths during the 16 years of 
follow-up. As noted by the authors, this is one of only a handful of studies to examine 
the association of waist circumference and mortality, with the others mostly showing 
strong associations. Two studies failed to show an association between waist 
circumference and mortality, but these were conducted in much older populations, 
which, although they may have substantial mortality, were less likely to present the 
full picture of obesity related premature mortality due to the changing associations 
between obesity and mortality with age13, 14.  
In the present paper, the authors have demonstrated among U.S. female nurses a 
clear step-wise increase in risk for each of cancer, CVD and overall mortality with 
increasing quintiles of waist circumference or waist:hip ratio. The J-shaped curve 
commonly seen in appropriately adjusted studies of BMI and mortality (which results 
largely from increased respiratory disease death among underweight individuals and 
increased CVD and cancer death among the overweight and obese) was not seen in 
this study. This demonstrates the difference in outcomes from overall obesity as 
compared with abdominal adiposity. Even though the results presented here suggest 
a roughly linear association between waist circumference and mortality, it needs to 
be acknowledged that there is a limit to the recommendation that a reduced waist 
circumference decreases mortality risk. Diseases such as anorexia and bulimia in 
more affluent societies, and the chronic malnutrition still present in much of the 
developing world, remind us that in another context, “underweight” can and does 
also present an increased mortality risk.  
The important debate as to which of waist circumference, waist:hip ratio and BMI is 
the “better” measure of obesity is probably best divided into clinical and research 
questions. In the busy clinical setting, the importance of this question relates to 
whether the time consuming burden of multiple measures of obesity is indeed 
justified. Various practical and scientific considerations are relevant here. Firstly, the 
simplicity of the message delivered by measurement of waist circumference to the 
individual or patient is of paramount importance. For example, who is unable  to 
relate to the experience of a pair of jeans that is feeling a little tight, or the belt that 
no longer quite fits? Both the BMI and waist:hip ratio are abstract concepts in 
comparison. Secondly, and just as importantly, abdominal obesity is a stronger 
predictor of obesity related outcomes, as demonstrated once again here by Zhang et 
al. Thirdly, and the only practical drawback with waist circumference, is that it is not 
easy to obtain an accurate waist measurement, with no standardized protocol 
practiced, and different studies using different locations  to take the measurement15. 
Even with a standard protocol, clinicians will differ in the measurement of an 
individual’s waist. Having said this, it is also true that obtaining an accurate weight 
measurement is also surprisingly difficult due to inaccuracies in scales used, the time 
of day and variation in the amount of clothing removed before measurement. Height 
measurement is also not always entirely accurate. Finally there is the question of 
whether the measurement of waist in addition to BMI helps to identify an additional 
subset of the population at increased risk? The findings from Zhang et al. clearly 
demonstrate that among those women classified as “normal” after measurement of 
BMI, the risk of mortality (and CVD mortality in particular) increases if they are also 
classified as obese by waist circumference. The same is true among those classified 
as normal by waist circumference, but obese by BMI. This would appear to suggest 
that in women, both BMI and waist circumference both provide important 
components of mortality risk.  
Does this mean that measurement of both central and overall adiposity in the clinical 
setting is justified? On the surface, it would appear so, however to answer this 
question fully requires both an analysis of whether models that include both are 
significantly better than those that contain waist circumference alone (for example, 
comparing the area under the ROC curve for both models) as well as an examination 
of the implications in a population setting. The correlation between continuous BMI 
and waist variables in the Nurses’ Health Study was high, reported as 0.81 by Zhang 
et al. Yet, the concordance of waist and BMI in categorizing the population into 
normal, overweight and obesity using established cut-points is not nearly so high. In 
the national Australian AusDiab study16, 95% of women who were classified as 
obese by BMI were also classified as obese by waist circumference, but conversely, 
only 58% of those deemed obese by waist circumference were also obese by BMI. 
Similarly, 85% of those classed as overweight by BMI are either overweight or obese 
by waist circumference, but only 63% of those overweight by waist are classified 
similarly or worse by BMI. The upshot of this is that even though BMI and waist are 
largely co-linear17, someone classified as overweight, or even more particularly 
obese, by BMI is overwhelmingly likely to be similarly classified by waist 
circumference, but not vice versa. The main reason for this is that using the cut-
points suggested for Europids, obesity defined using waist circumference identifies a 
much larger proportion of the population than does obesity defined by BMI. So even 
though the mortality risk may be higher in those identified as obese by both waist 
and BMI, in reality, measuring BMI in addition to waist will not identify a large 
additional population at higher risk (at least using currently recommended cut-
points18), whereas using waist circumference alone will identify both those already 
identified by BMI as obese, plus a significant additional high risk population. 
Summarization of all of these arguments leads to the conclusion that monitoring 
changes in waist size (whether or not the cut-points are taken into consideration) is 
as important, or even more important, than monitoring changes in weight and BMI. 
The findings of Zhang et al. confirm the importance of this, at least for women 
(analysis of similar male cohorts is therefore also required to confirm these findings 
for both sexes). The simple measurement of waist circumference should be strongly 
encouraged in the clinical setting, and also as a health promotion message to 
encourage prevention of the multiple obesity related outcomes such as type 2 
diabetes, CVD, and also death. 
An interesting and controversial facet of the relationship between obesity and 
mortality that was not addressed in the report of Zhang et al., is the changes in this 
relationship that occur with age. Obesity has different implications not only based on 
the degree of severity, but also on the age at which it develops. This is a reality and 
an issue that is seldom addressed, usually due to the absence of lifetime data, or 
inadequate numbers of subjects and events in order to analyze mortality by age 
group. Stevens et al. addressed this question in their analysis of the relationship 
between age, BMI and mortality in the large American Cancer Prevention Study, 
demonstrating that the strength of the relationship between mortality and BMI 
declined with age (even though it remained significant up to age 74 years)8. This 
could explain the absence of an association between waist circumference and 
mortality seen in those two studies that only included elderly subjects13, 14, and 
suggests that, while obesity needs to be recognized as an important risk factor for 
mortality (and other outcomes), this message needs to be particularly directed at 
younger populations. The heightened risk of obesity in younger populations is 
twofold – firstly, they have a lifetime in which the consequences of their obesity can 
be played out, and secondly, they have a longer time in which their adiposity can 
further increase. For these reasons, a push to curb childhood and adolescent obesity 
is of paramount importance.  
A final mention of the novel findings regarding the strong relationship between 
central obesity and cancer mortality in the present study should be made. These 
results are of great importance and serve to further highlight the multi-faceted nature 
of the consequences of an obesity epidemic. The multiple important messages about 
the consequences of obesity present in this paper come at an opportune time, with 
little evidence to date of the paradigm shift in thinking required to prevent a 
worsening of the obesity-related crisis and to attack the environmental and 
behavioural issues that are creating the obesogenic environment that surrounds us. 
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